Sequential somatic mutations upon secondary anti-HER2 treatment resistance in metastatic ERBB2(S310F) mutated extramammary Paget’s disease

Metastatic extramammary Paget’s disease is a rare adenocarcinoma with poor prognosis. Several reports of human epidermal growth factor receptor 2 alterations point to its pathogenic role in the disease. However, the occurrence of treatment resistance to anti-HER2 therapy demand the need for further...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Nordmann, Thierry M., Messerli-Odermatt, Olivia, Meier, Larissa, Micaletto, Sara, Coppetti, Thomas, Nägeli, Mirjam, Kamarachev, Jivko, Kudura, Ken, Freiberger, Sandra N., Rordorf, Tamara, Mangana, Joanna, Braun, Ralph, Dummer, Reinhard
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2019
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6877105/
https://ncbi.nlm.nih.gov/pubmed/31803359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27272
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados